Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities-Reference-Cited by-同舟云学术

Clinical use of Convalescent Plasma in the COVID‐19 pandemic: a transfusion‐focussed gap analysis with recommendations for future research priorities

Published:2020-09-03 Issue:1 Volume:116 Page:88-98
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Al‐Riyami Arwa Z.¹^ORCID,Schäfer Richard²,Berg Karin³⁴,Bloch Evan M.⁵^ORCID,Estcourt Lise J.⁶,Goel Ruchika⁷⁸,Hindawi Salwa⁹^ORCID,Josephson Cassandra D.¹⁰¹¹,Land Kevin¹²¹³,McQuilten Zoe K.¹⁴¹⁵,Spitalnik Steven L.¹⁶,Wood Erica M.¹⁴¹⁵,Devine Dana V.¹⁷¹⁸,So‐Osman Cynthia¹⁹²⁰^ORCID

Affiliation:

1. Department of Haematology Sultan Qaboos University Hospital Muscat Sultanate of Oman

2. Institute for Transfusion Medicine and Immunohaematology German Red Cross Blood Donor Service Baden‐Württemberg‐Hessen gGmbH Goethe University Hospital Frankfurt am Main Germany

3. Medical Division Translational Research Department South African National Blood Service Port Elizabeth South Africa

4. Division Clinical Haematology Department of Medicine University of Cape Town Cape Town South Africa

5. Department of Pathology Johns Hopkins University School of Medicine Baltimore MD USA

6. Radcliffe Department of Medicine University of Oxford and NHS Blood and Transplant Oxford UK

7. Division of Transfusion Medicine Department of Pathology Johns Hopkins Hospital Baltimore MD USA

8. Division of Hematology/Oncology Simmons Cancer Institute at SIU School of Medicine and Mississippi Valley Regional Blood Center Springfield IL USA

9. Haematology Department Faculty of Medicine King Abdulaziz University Jeddah Saudi Arabia

10. Department of Pathology and Laboratory Medicine Center for Transfusion and Cellular Therapies Emory University School of Medicine Atlanta GE USA

11. Department of Pediatrics Aflac Cancer Center and Blood Disorders Children's Healthcare of Atlanta Emory University School of Medicine Atlanta GE USA

12. Corporate Medical Affairs Vitalant Phoenix AZ USA

13. Department of Pathology UT Health Science San Antonio San Antonio TX USA

14. Transfusion Research Unit School of Public Health and Preventive Medicine Monash University Melbourne VIC Australia

15. Department of Clinical Haematology Monash Health Melbourne VIC Australia

16. Department of Pathology & Cell Biology Columbia University New York NY USA

17. Canadian Blood Services Vancouver BC Canada

18. Department of Pathology & Laboratory Medicine University of British Columbia Vancouver BC Canada

19. Department Unit Transfusion Medicine Sanquin Blood Supply Foundation Amsterdam The Netherlands

20. Department Haematology Erasmus Medical Center Rotterdam The Netherlands

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.12973

Reference60 articles.

1. World Health Organization:Coronavirus disease (COVID‐19) outbreak.https://www.who.int/westernpacific/emergencies/covid‐19. Published2020. [Last accessed 1st May 2020]

2. A serological survey on neutralizing antibody titer of SARS convalescent sera

3. The convalescent sera option for containing COVID-19

4. Convalescent plasma in Covid-19: Possible mechanisms of action

5. Use of Convalescent Measles Serum to Control Measles in a Preparatory School

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perceptions of Saudis Toward Participating in the COVID-19 Convalescent Plasma Clinical Trial;Cureus;2023-11-16

2. The Impact of Pathogen Reduction on Total IgG and IgG Subclass Profiles of Convalescent Plasma;Transfusion Medicine and Hemotherapy;2023-06-21

3. Convalescent plasma – An insight into a novel treatment of covid-19 ICU patients;Transfusion and Apheresis Science;2022-12

4. ‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review;Infectious Disorders - Drug Targets;2022-12

5. Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility;Vox Sanguinis;2022-09-14